Search Results

You are looking at 11 - 20 of 319 items for :

  • "incidence" x
Clear All
Valentina M. Drozd The International Fund “Help for patients with radiation-induced thyroid cancer ‘Arnica’”, Minsk, Belarus
Project Chernobyl, Brooklyn, New York, USA

Search for other papers by Valentina M. Drozd in
Google Scholar
PubMed
Close
,
Igor Branovan Project Chernobyl, Brooklyn, New York, USA

Search for other papers by Igor Branovan in
Google Scholar
PubMed
Close
,
Nikolay Shiglik Project Chernobyl, Brooklyn, New York, USA

Search for other papers by Nikolay Shiglik in
Google Scholar
PubMed
Close
,
Johannes Biko Clinic and Polyclinic of Nuclear Medicine, University of Würzburg, Würzburg, Germany

Search for other papers by Johannes Biko in
Google Scholar
PubMed
Close
, and
Christoph Reiners The International Fund “Help for patients with radiation-induced thyroid cancer ‘Arnica’”, Minsk, Belarus
Clinic and Polyclinic of Nuclear Medicine, University of Würzburg, Würzburg, Germany

Search for other papers by Christoph Reiners in
Google Scholar
PubMed
Close

Introduction During the last 30 years, the incidence of differentiated thyroid cancer (DTC) has steadily increased worldwide, most markedly in France, Italy, the Republic of Korea, Australia, and the USA [ 1 - 8 ]. In the USA, DTC incidence is

Open access
Inês Cosme Department of Endocrinology, Unidade Local de Saúde Santa Maria, Lisbon, Portugal

Search for other papers by Inês Cosme in
Google Scholar
PubMed
Close
,
Ana Figueiredo Department of Endocrinology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Ana Figueiredo in
Google Scholar
PubMed
Close
,
Sara Pinheiro Department of Endocrinology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Sara Pinheiro in
Google Scholar
PubMed
Close
, and
Valeriano Leite Department of Endocrinology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Close

Introduction The incidence of thyroid carcinoma (TC) increased over the past 50 years ( 1 , 2 ) mainly due to a disproportionate increase in small papillary TC ( 3 ). In 2020, the GLOBOCAN database reported worldwide 586,000 cases of TC

Open access
Catherine Brophy Departments of Otolaryngology - Head and Neck Surgery, Cork, Ireland

Search for other papers by Catherine Brophy in
Google Scholar
PubMed
Close
,
Rania Mehanna Departments of Otolaryngology - Head and Neck Surgery, Cork, Ireland

Search for other papers by Rania Mehanna in
Google Scholar
PubMed
Close
,
Julie McCarthy Departments of Cytopathology, Cork University Hospital, Cork, Ireland

Search for other papers by Julie McCarthy in
Google Scholar
PubMed
Close
,
Antoinette Tuthill Departments of Endocrinology, Cork University Hospital, Cork, Ireland

Search for other papers by Antoinette Tuthill in
Google Scholar
PubMed
Close
,
Matthew S. Murphy Departments of Endocrinology, South Infirmary Victoria University Hospital, Cork, Ireland

Search for other papers by Matthew S. Murphy in
Google Scholar
PubMed
Close
, and
Patrick Sheahan Departments of Otolaryngology - Head and Neck Surgery, Cork, Ireland

Search for other papers by Patrick Sheahan in
Google Scholar
PubMed
Close

Introduction Thyroid nodules are common, being present by palpation in up to 5% of individuals and by ultrasonography (US) in up to 50% [ 1 ]. While the overwhelming majority are benign, it is estimated that the incidence of cancer in

Free access
Line Tang Møllehave Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark

Search for other papers by Line Tang Møllehave in
Google Scholar
PubMed
Close
,
Nils Knudsen Department of Endocrinology, Bispebjerg University Hospital, University of Copenhagen, Denmark

Search for other papers by Nils Knudsen in
Google Scholar
PubMed
Close
,
Allan Linneberg Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Allan Linneberg in
Google Scholar
PubMed
Close
,
Inge Bülow Pedersen Department of Endocrinology and Medicine, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Close
,
Gitte Ravn-Haren Research Group for Risk Benefit, National Food Institute, Technical University of Denmark, Lyngby, Denmark

Search for other papers by Gitte Ravn-Haren in
Google Scholar
PubMed
Close
,
Anja Lykke Madsen Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark

Search for other papers by Anja Lykke Madsen in
Google Scholar
PubMed
Close
,
Allan Carlé Department of Endocrinology and Medicine, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by Allan Carlé in
Google Scholar
PubMed
Close
,
Charlotte Cerqueira The Danish Clinical Quality Program – National Clinical Registries (RKKP), Denmark

Search for other papers by Charlotte Cerqueira in
Google Scholar
PubMed
Close
,
Anne Krejbjerg Department of Oncology, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by Anne Krejbjerg in
Google Scholar
PubMed
Close
,
Lone Banke Rasmussen Independent researcher, Klemensker, Denmark

Search for other papers by Lone Banke Rasmussen in
Google Scholar
PubMed
Close
,
Lars Ovesen Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark

Search for other papers by Lars Ovesen in
Google Scholar
PubMed
Close
,
Hans Perrild Department of Endocrinology, Bispebjerg University Hospital, University of Copenhagen, Denmark

Search for other papers by Hans Perrild in
Google Scholar
PubMed
Close
,
Lena Bjergved Sigurd Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Internal Medicine, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark

Search for other papers by Lena Bjergved Sigurd in
Google Scholar
PubMed
Close
,
Betina Heinsbæk Thuesen Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark

Search for other papers by Betina Heinsbæk Thuesen in
Google Scholar
PubMed
Close
,
Pernille Vejbjerg Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark

Search for other papers by Pernille Vejbjerg in
Google Scholar
PubMed
Close
, and
Torben Jørgensen Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Torben Jørgensen in
Google Scholar
PubMed
Close

(11.8–12.2 mL, P < 0.001) ( 58 ). Effects on thyroid disorders Hyperthyroidism The laboratory studies found that before IF, in 1997–1998, the incidence of overt hyperthyroidism was 128.5 and 80.1 per 100,000 person-years (PY) in western

Open access
Juan J. Lence-Anta Institute of Oncology and Radiobiology, Havana, Cuba

Search for other papers by Juan J. Lence-Anta in
Google Scholar
PubMed
Close
,
Constance Xhaard Radiation Epidemiology Group, 1018 INSERM Unit, Havana, Cuba
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France

Search for other papers by Constance Xhaard in
Google Scholar
PubMed
Close
,
Rosa M. Ortiz Institute of Oncology and Radiobiology, Havana, Cuba

Search for other papers by Rosa M. Ortiz in
Google Scholar
PubMed
Close
,
Haoiinda Kassim Radiation Epidemiology Group, 1018 INSERM Unit, Havana, Cuba
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France

Search for other papers by Haoiinda Kassim in
Google Scholar
PubMed
Close
,
Celia M. Pereda Institute of Oncology and Radiobiology, Havana, Cuba

Search for other papers by Celia M. Pereda in
Google Scholar
PubMed
Close
,
Silvia Turcios National Institute of Endocrinology, Havana, Cuba

Search for other papers by Silvia Turcios in
Google Scholar
PubMed
Close
,
Milagros Velasco Institute of Oncology and Radiobiology, Havana, Cuba

Search for other papers by Milagros Velasco in
Google Scholar
PubMed
Close
,
Mae Chappe Institute of Oncology and Radiobiology, Havana, Cuba

Search for other papers by Mae Chappe in
Google Scholar
PubMed
Close
,
Idalmis Infante Institute of Oncology and Radiobiology, Havana, Cuba

Search for other papers by Idalmis Infante in
Google Scholar
PubMed
Close
,
Marlene Bustillo Institute of Oncology and Radiobiology, Havana, Cuba

Search for other papers by Marlene Bustillo in
Google Scholar
PubMed
Close
,
Anabel García Institute of Oncology and Radiobiology, Havana, Cuba

Search for other papers by Anabel García in
Google Scholar
PubMed
Close
,
Enora Clero Radiation Epidemiology Group, 1018 INSERM Unit, Havana, Cuba
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France

Search for other papers by Enora Clero in
Google Scholar
PubMed
Close
,
Stephane Maillard Radiation Epidemiology Group, 1018 INSERM Unit, Havana, Cuba
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France

Search for other papers by Stephane Maillard in
Google Scholar
PubMed
Close
,
Sirced Salazar Institute of Oncology and Radiobiology, Havana, Cuba

Search for other papers by Sirced Salazar in
Google Scholar
PubMed
Close
,
Regla Rodriguez Cuban Health Public Ministry, Havana, Cuba

Search for other papers by Regla Rodriguez in
Google Scholar
PubMed
Close
, and
Florent de Vathaire Radiation Epidemiology Group, 1018 INSERM Unit, Havana, Cuba
Institut Gustave Roussy, Havana, Cuba
University Paris-Sud, Villejuif, France

Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
Close

Introduction Registering the incidence of differentiated thyroid carcinoma (DTC) is highly dependent on the medical practice and, in particular, on organized or opportunistic screening [ 1 ]. Therefore, comparing reported incidences requires

Free access
Maria Rossing Department of Endocrinology, Herlev University Hospital, Herlev
Center of Genomic Medicine, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Maria Rossing in
Google Scholar
PubMed
Close
,
Birte Nygaard Department of Endocrinology, Herlev University Hospital, Herlev

Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Close
,
Finn Cilius Nielsen Center of Genomic Medicine, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Finn Cilius Nielsen in
Google Scholar
PubMed
Close
, and
Finn Noe Bennedbæk Department of Endocrinology, Herlev University Hospital, Herlev

Search for other papers by Finn Noe Bennedbæk in
Google Scholar
PubMed
Close

Frates et al. [ 7 ] the accumulated predicted value of US characteristics and basic clinical features ranged between 3 and 48%. The papillary thyroid microcarcinoma (PTMC) is a papillary thyroid carcinoma with a size of ≤1 cm. The overall incidence of

Open access
Lan Wu State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Lan Wu in
Google Scholar
PubMed
Close
,
Salvatore Vaccarella International Agency for Research on Cancer (IARC/WHO), Lyon, France

Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Close
,
Chen-Yang Feng Information Technology Center, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Chen-Yang Feng in
Google Scholar
PubMed
Close
,
Luigino Dal Maso Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy

Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Close
,
Yu Chen State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Yu Chen in
Google Scholar
PubMed
Close
,
Wei-Wei Liu Department of Head and Neck, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Wei-Wei Liu in
Google Scholar
PubMed
Close
,
Miao-Bian Liang State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Miao-Bian Liang in
Google Scholar
PubMed
Close
,
Zike Zhang Department of Laboratory Medicine, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Search for other papers by Zike Zhang in
Google Scholar
PubMed
Close
,
Jun Yang School of Public Health, Guangzhou Medical University, Guangzhou, China

Search for other papers by Jun Yang in
Google Scholar
PubMed
Close
,
Su-Mei Cao State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Su-Mei Cao in
Google Scholar
PubMed
Close
, and
Mengmeng Li State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Mengmeng Li in
Google Scholar
PubMed
Close

Introduction Thyroid cancer is the most common cancer in the endocrine system, and its incidence rates have increased rapidly worldwide over the past decades, with relatively stable or declining mortality rates ( 1 , 2 ). The diverging gap

Open access
L.A. Jonker Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by L.A. Jonker in
Google Scholar
PubMed
Close
,
C.A. Lebbink Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Search for other papers by C.A. Lebbink in
Google Scholar
PubMed
Close
,
M.C.J. Jongmans Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by M.C.J. Jongmans in
Google Scholar
PubMed
Close
,
R.A.J. Nievelstein Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Department of Pediatric Radiology and Nuclear Medicine, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by R.A.J. Nievelstein in
Google Scholar
PubMed
Close
,
J.H.M. Merks Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Search for other papers by J.H.M. Merks in
Google Scholar
PubMed
Close
,
E.J.M. Nieveen van Dijkum Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands

Search for other papers by E.J.M. Nieveen van Dijkum in
Google Scholar
PubMed
Close
,
T.P. Links Department of Endocrinology, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by T.P. Links in
Google Scholar
PubMed
Close
,
N. Hoogerbrugge Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by N. Hoogerbrugge in
Google Scholar
PubMed
Close
,
A.S.P. van Trotsenburg Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands

Search for other papers by A.S.P. van Trotsenburg in
Google Scholar
PubMed
Close
, and
H.M. van Santen Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Search for other papers by H.M. van Santen in
Google Scholar
PubMed
Close

any childhood cancer may be justified when its incidence reaches 5%, also for tumors with a good prognosis [ 8 , 9 ]. For this reason, the first question that needs to be answered is about the incidence of DTC in children with PHTS. The second

Open access
Carla Colombo Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Search for other papers by Carla Colombo in
Google Scholar
PubMed
Close
,
Daniele Ceruti Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Close
,
Simone De Leo Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy

Search for other papers by Simone De Leo in
Google Scholar
PubMed
Close
,
Grzegorz Bilo Department of Cardiology, San Luca Hospital, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy

Search for other papers by Grzegorz Bilo in
Google Scholar
PubMed
Close
,
Matteo Trevisan Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Close
,
Noemi Giancola Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Search for other papers by Noemi Giancola in
Google Scholar
PubMed
Close
,
Claudia Moneta Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Close
,
Gianfranco Parati Department of Cardiology, San Luca Hospital, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy

Search for other papers by Gianfranco Parati in
Google Scholar
PubMed
Close
,
Luca Persani Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy

Search for other papers by Luca Persani in
Google Scholar
PubMed
Close
, and
Laura Fugazzola Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Close

most frequent toxicities recorded during both clinical trials and real-life (RL) studies and has a high incidence during LEN treatment (reviewed in Table 1 ). Indeed, in the LEN registration trial SELECT, it was recorded in 67.8% of cases, and 41.8% of

Open access
Dillwyn Williams Department of Public Health, University of Cambridge, Cambridge, UK

Search for other papers by Dillwyn Williams in
Google Scholar
PubMed
Close

areas needs to be considered: the age-specific incidence of thyroid malignancy, the age-related sensitivity to radiation-induced thyroid cancer, the molecular findings in malignancy, the cell of origin of thyroid carcinomas, and the growth pattern of the

Free access